Proof of concept nanotechnological approach to in vitro targeting of malignant melanoma for enhanced immune checkpoint inhibition
Open Access
- 8 May 2023
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-16
Abstract
Immunotherapies, including immune checkpoint inhibitors, have limitations in their effective treatment of malignancies. The immunosuppressive environment associated with the tumor microenvironment may prevent the achievement of optimal outcomes for immune checkpoint inhibitors alone, and nanotechnology-based platforms for delivery of immunotherapeutic agents are increasingly being investigated for their potential to improve the efficacy of immune checkpoint blockade therapy. In this manuscript, nanoparticles were designed with appropriate size and surface characteristics to enhance their retention of payload so that they can transmit their loaded drugs to the tumor. We aimed to enhance immune cell stimulation by a small molecule inhibitor of PD-1/PD-L1 (BMS202) using nanodiamonds (ND). Melanoma cells with different disease stages were exposed to bare NDs, BMS202-NDs or BMS202 alone for 6 h. Following this, melanoma cells were co-cultured with freshly isolated human peripheral blood mononuclear cells (hPBMCs). The effects of this treatment combination on melanoma cells were examined on several biological parameters including cell viability, cell membrane damage, lysosomal mass/pH changes and expression of γHA2X, and caspase 3. Exposing melanoma cells to BMS202-NDs led to a stronger than normal interaction between the hPBMCs and the melanoma cells, with significant anti-proliferative effects. We therefore conclude that melanoma therapy has the potential to be enhanced by non-classical T-cell Immune responses via immune checkpoint inhibitors delivered by nanodiamonds-based nanoparticles.Keywords
This publication has 98 references indexed in Scilit:
- Citrullination as early-stage indicator of cell response to Single-Walled Carbon NanotubesScientific Reports, 2013
- Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic MelanomaClinical Cancer Research, 2011
- The Role of Autophagy in Cancer: Therapeutic ImplicationsMolecular Cancer Therapeutics, 2011
- Nanomaterials for Cancer Therapy and ImagingMolecules and Cells, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Activation of stress-related signalling pathway in human cells upon SiO2 nanoparticles exposure as an early indicator of cytotoxicityJournal of Nanobiotechnology, 2011
- Development of Ipilimumab: Contribution to a New Paradigm for Cancer ImmunotherapySeminars in Oncology, 2010
- Lysosomal membrane permeabilization in cell deathOncogene, 2008
- H2AX phosphorylation within the G 1 phase after UV irradiation depends on nucleotide excision repair and not DNA double-strand breaksProceedings of the National Academy of Sciences, 2006
- Cellular injury induced by oxidative stress is mediated through lysosomal damageFree Radical Biology and Medicine, 1995